Roslin Technologies Limited

Roslin Technologies is an Edinburgh-based food and agricultural biotechnology company that specializes in the development and commercialization of animal stem cells for the cultivated meat industry. Founded in 2017 as a venture involving the University of Edinburgh, the company leverages advanced biotechnologies to provide high-quality pluripotent stem cell lines, including induced pluripotent stem cells (iPSCs) and embryo-derived stem cells (ESCs) for species such as bovine, porcine, and ovine. These cells are designed for long-term growth, genetic stability, and differentiation into muscle and fat tissues. Beyond cell lines, the company provides comprehensive support packages that include food-safe growth media, scalable bioprocess protocols, cell banking, and technical data necessary for regulatory food safety assessments.

By supplying these advanced cell-based solutions, Roslin Technologies enables cultivated meat producers globally to accelerate product development, reduce production costs, and overcome manufacturing risks. The company’s work addresses the rising global demand for protein by providing a more sustainable, animal-friendly, and efficient alternative to traditional livestock production. With a diverse international customer base spanning North America, Europe, Asia, and the Middle East, the company collaborates with food tech startups and major food corporations to bring cultivated meat products to market. Through continued investment and research, including its focus on cell biomass scale-up and intellectual property expansion, Roslin Technologies aims to foster a more resilient and sustainable global food system.